Major eye drop and ointment recalls in 2025
Throughout 2025, several ophthalmic products were voluntarily recalled nationwide by manufacturers and distributors in cooperation with the FDA. These recalls addressed safety concerns such as potential fungal contamination and manufacturing issues, with affected products including popular brands and generic versions. Consumers and healthcare providers were urged to stop using these products immediately to avoid potential health risks.
Alcon recalls Systane eye drops
Alcon Laboratories issued a recall for one lot of Systane Lubricant Eye Drops Ultra PF, Lot 10101, in early 2025, following a consumer report of fungal material in a sealed vial. This posed a risk of eye infections, particularly for those with weakened immune systems.
AvKARE recalls ophthalmic solutions and gels
In May 2025, distributor AvKARE recalled various over-the-counter ophthalmic products after an FDA audit found manufacturing practice deviations that raised concerns about sterility. This FDA Class II recall affected products distributed from May 2023 to April 2025, including different types of artificial tears and gels.
Brassica Pharma recalls eye ointments
On February 26, 2025, eye ointments manufactured by Brassica Pharma Pvt. Ltd. were recalled due to sterility concerns. These products were sold under the Equate, CVS Health, and AACE Pharmaceuticals brands and were available at retailers like Walmart and CVS.
Apotex recalls prescription eye drops
In July 2025, Apotex recalled specific prescription eye drops, including a glaucoma treatment, due to an unspecified quality issue. Patients were advised to check if their medication batches were affected, specifically Ketorolac Tromethamine Ophthalmic Solution, 0.5% (Batch TZ1236), and Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% (Batch VC6058).
Eye drop recalls in 2025: At a glance
Recall by | Distributor(s) | Products Recalled | Reason for Recall | Status |
---|---|---|---|---|
Alcon | Retail & Internet Outlets | Systane Lubricant Eye Drops Ultra PF, Lot 10101 | Potential fungal contamination | Voluntary Nationwide Recall |
BRS Analytical Service | AvKARE | Artificial Tears, Carboxymethylcellulose Gel & Solution, Lubricant Eye Drops, Polyvinyl Alcohol Ophthalmic Solution | Manufacturing deviations, lack of sterility assurance | FDA Class II Recall |
Brassica Pharma | CVS, Walmart | CVS Health Lubricant Eye Ointment, Equate Lubricant Eye Ointment, AACE Pharma PM Ointment | Sterility concerns | FDA Recall Notice |
Apotex | Various Healthcare Providers | Ketorolac Tromethamine Ophthalmic Solution, Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution | Unspecified quality issue leading to recall | Nationwide Recall |
What to do if you have recalled eye drops
If you have a recalled eye product, immediately stop using it. You can return it to the place of purchase for a refund or dispose of it safely, following any specific instructions from the FDA or manufacturer. If you experience any adverse effects like pain or vision changes, contact a healthcare provider and inform them about the recalled product. You can also report adverse reactions to the FDA's MedWatch program.
Ensuring eye drop safety
To help ensure the safety of your eye drops, buy products from trusted retailers and check packaging for damage and expiration dates. Use products as directed by the manufacturer and store them properly to prevent contamination. Regularly checking the FDA's website for drug safety and recall information is also recommended. You can find this information on the FDA's drug safety and availability section online.
Conclusion
The 2025 eye drop and ointment recalls, involving products from brands like Systane, AvKARE, Equate, and CVS Health, underscore the critical need for strict manufacturing quality control. Issues such as fungal contamination and manufacturing practice violations can lead to serious health risks, including vision-threatening infections. Consumers should actively check for recalled products and immediately discontinue using any affected items. By staying informed and taking appropriate action, individuals can help protect their eye health. Healthcare providers and retailers are also key in removing recalled products and raising consumer awareness.